Poulsen Thomas T, Pedersen Nina, Perin Mark S, Hansen Celia K, Poulsen Hans S
Department of Radiation Biology, Section 6321, Finsen Center, National University Hospital, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark.
Lung Cancer. 2005 Dec;50(3):329-37. doi: 10.1016/j.lungcan.2005.06.011. Epub 2005 Aug 22.
Small cell lung cancer (SCLC) is a malignant disease, for which no satisfactory treatment is presently available and consequently, new specific therapeutic targets are in high demand. A global gene expression analysis previously performed, identified the neuronal pentraxin receptor (NPR) as highly and relatively specifically expressed in SCLC, consistent with the neuroendocrine features of this cancer. Normally, NPR is exclusively expressed in neurons, where it associates with the homologous proteins neuronal pentraxins 1 and 2 (NP1 and NP2) in complexes capable of binding the snake venom neurotoxin taipoxin. The purpose of the present study was to assess the toxic effect of taipoxin in SCLC-cell lines and to determine if toxicity correlates to NPR and NP1 and NP2 expression levels. NPR was detected by Western blot analysis in all the tested SCLC and in control cell lines of different origin. The receptor co-purified with cell membrane in SCLC, indicating that NPR is surface associated. Microarray signals for NP1 and NP2mRNA was detected in a subset of SCLC-cell lines and validated by Northern blot analysis. Furthermore, NP1 protein was detected by Western blot analysis in a few SCLC-cell lines, but not in the control cell lines. A number of SCLC-cell lines showed marked sensitivity to taipoxin (IC50: 3-130 nM) at toxin concentrations leaving the control cell lines unaffected. The sensitivity to taipoxin did not correlate with the expression levels of NP1 protein and NP2-mRNA, suggesting that expression of these proteins may not be required for taipoxin induced toxicity in SCLC. The demonstrated toxic effect of taipoxin in SCLC may prove to be of importance for designing novel specific treatment modalities for this disease.
小细胞肺癌(SCLC)是一种恶性疾病,目前尚无令人满意的治疗方法,因此,对新的特异性治疗靶点有很高的需求。先前进行的一项全球基因表达分析确定,神经元五聚体受体(NPR)在SCLC中高度且相对特异性表达,这与该癌症的神经内分泌特征一致。正常情况下,NPR仅在神经元中表达,在那里它与同源蛋白神经元五聚体1和2(NP1和NP2)结合形成能够结合蛇毒神经毒素 taipoxin 的复合物。本研究的目的是评估 taipoxin 对 SCLC 细胞系的毒性作用,并确定毒性是否与 NPR、NP1 和 NP2 的表达水平相关。通过蛋白质印迹分析在所有测试的 SCLC 和不同来源的对照细胞系中检测到 NPR。该受体在 SCLC 中与细胞膜共纯化,表明 NPR 与表面相关。在一部分 SCLC 细胞系中检测到 NP1 和 NP2mRNA 的微阵列信号,并通过 Northern 印迹分析进行了验证。此外,通过蛋白质印迹分析在少数 SCLC 细胞系中检测到 NP1 蛋白,但在对照细胞系中未检测到。许多 SCLC 细胞系在毒素浓度下对 taipoxin 表现出明显的敏感性(IC50:3 - 130 nM),而对照细胞系未受影响。对 taipoxin 的敏感性与 NP1 蛋白和 NP2 - mRNA 的表达水平无关,这表明这些蛋白对于 taipoxin 在 SCLC 中诱导的毒性可能不是必需的。已证明的 taipoxin 对 SCLC 的毒性作用可能对设计针对该疾病的新型特异性治疗方法具有重要意义。